Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN – Research Report), Sarepta Therapeutics (SRPT – Research Report) and Karuna Therapeutics (KRTX – Research Report). Amgen (AMGN) In a report released today, Steve Chesney from Atlantic Equities maintained a Sell rating on Amgen, with a price target of $182.00. The company's shares closed last Monday at $247.29. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-sarepta-therapeutics-srpt-and-karuna-therapeutics-krtx?utm_source=advfn.com&utm_medium=referral
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Sarepta Therapeutics Charts.
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Sarepta Therapeutics Charts.